[go: up one dir, main page]

CH639272A5 - Anticarcinoma composition - Google Patents

Anticarcinoma composition Download PDF

Info

Publication number
CH639272A5
CH639272A5 CH526878A CH526878A CH639272A5 CH 639272 A5 CH639272 A5 CH 639272A5 CH 526878 A CH526878 A CH 526878A CH 526878 A CH526878 A CH 526878A CH 639272 A5 CH639272 A5 CH 639272A5
Authority
CH
Switzerland
Prior art keywords
fluorouracil
uracil
cancer
compound
composition according
Prior art date
Application number
CH526878A
Other languages
German (de)
English (en)
Inventor
Setsuro Fujii
Norio Unemi
Setsuo Takeda
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11867814&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CH639272(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of CH639272A5 publication Critical patent/CH639272A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH526878A 1978-02-10 1978-05-16 Anticarcinoma composition CH639272A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP53014676A JPS5953885B2 (ja) 1978-02-10 1978-02-10 抗腫瘍剤組成物

Publications (1)

Publication Number Publication Date
CH639272A5 true CH639272A5 (en) 1983-11-15

Family

ID=11867814

Family Applications (1)

Application Number Title Priority Date Filing Date
CH526878A CH639272A5 (en) 1978-02-10 1978-05-16 Anticarcinoma composition

Country Status (3)

Country Link
JP (1) JPS5953885B2 (it)
CH (1) CH639272A5 (it)
IT (1) IT1109133B (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE141506T1 (de) * 1990-09-07 1996-09-15 Taiho Pharmaceutical Co Ltd Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53124624A (en) * 1977-04-05 1978-10-31 Taiho Pharmaceutical Co Ltd Antiitumor agent

Also Published As

Publication number Publication date
JPS5953885B2 (ja) 1984-12-27
IT1109133B (it) 1985-12-16
JPS54107527A (en) 1979-08-23
IT7868220A0 (it) 1978-05-26

Similar Documents

Publication Publication Date Title
DE69627042T2 (de) Isocumarinderivate und deren verwendung in medikamenten
DE69430587T2 (de) Pyrimidin-acyclonukleosid-derivate
EP0041215B1 (de) Imidazoazolalkensäureamide, neue Zwischenprodukte zu ihrer Herstellung, ihre Herstellung und ihre Verwendung in Arzneimitteln
DE2923368A1 (de) Neue 5-fluor-( beta -uridin oder 2'-desoxy- beta -uridin)-derivate, verfahren zur herstellung derselben und carcinostatische mittel mit einem gehalt derselben
DE68925270T2 (de) Pyrrolo[3,2-e]pyrazolo[1,5-a]pyrimidinderivate und diese enthaltende Arzneimittel
EP0003029B1 (de) Neue 2-Oxo-1-pyrrolidinessigsäurederivate, Verfahren zu ihrer Herstellung, diese enthaltende Arzneimittel und deren Herstellung
DE69126469T2 (de) Pyrimidin-Nukleosid-Derivate und antivirale Mittel, die diese Derivate als aktiven Bestandteil enthalten
DE60012288T2 (de) Antivirale pyrimidindion-derivate und verfahren zu ihrer herstellung
DE3416695A1 (de) Amidinohydrazone von tetralin-, chromon-, thiochromon- und tretrahydrochinolin-derivaten, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE69623760T2 (de) Kaliumionen-kanal-blocker
DE69719511T2 (de) Antivirale 2,4-pyrimidindion-derivate und verfahren zu ihrer herstellung
DE2831761C2 (de) 2,3- und 2,3,6-substituierte-4-Pyrone und deren Verwendung
DE2523103A1 (de) Neue propargyl-2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben
EP0093252B1 (de) Thiomethylpyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2814202C2 (de) Verwendung von Uracilderivaten zur Bekämpfung von Krebs oder krebsartigen Erkrankungen
DE1593728C3 (de) Substituierte Amidine und Verfahren zu ihrer Herstellung
DE2639135A1 (de) 1-carbamoyl-5-fluorouracilderivate und ihre verwendung zur tumortherapie
CH642668A5 (de) 2,6-diaminonebularine, verfahren zu deren herstellung und sie enthaltende pharmazeutische praeparate.
DE1470284B1 (de) Beta-{1-Methyl-4-[1-methyl-4-(1-methyl-4-formylamino-pyrrol-2-carboxamido)-pyrrol-2-carboxamido]-pyrrol-2-carboxamido}-propionamidin sowie dessen Saeureadditionssalze
DE3447003A1 (de) 7-acylamino-9a-methoxymitosane, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische mittel
EP0110219B1 (de) Heterocyclisch substituierte Nitrile, ihre Herstellung und Verwendung als Arzneimittel
CH639272A5 (en) Anticarcinoma composition
EP0088323B1 (de) Imidazothiadiazolalkencarbonsäureamide, neue Zwischenprodukte zu ihrer Herstellung, ihre Herstellung und ihre Verwendung in Arzneimitteln
DE3709699C2 (de) 5-Fluoruracil-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE2650366C3 (de) Verwendung eines 5-Fluoruracilde-

Legal Events

Date Code Title Description
PL Patent ceased